Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Centerra Gold

2 Buy-Rated Dividend Gold Stocks With Over 2% Yield

Two buy-rated dividend gold stocks, Centerra Gold and Barrick Gold, are offering attractive yields of over 2% and strong growth prospects, making them compelling additions to a diversified portfolio. With gold prices expected to continue rising, these stocks provide a unique combination of capital appreciation and steady income.

Barchart

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022

Benzinga

Centerra Gold's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Centerra Gold (NYSE:CGAU).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Centerra Gold: Q1 Earnings Insights

Centerra Gold (NYSE:CGAU) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Centerra Gold reported in-line EPS of $0.19 versus an estimate of $0.19.

Benzinga

Gold and Silver in 2022: The Complete Investors Guide

While many investors choose to invest in precious metals through ETFs, coins, or bullion, another option is to invest in gold and silver mining stocks. During bull markets, miners are the best performing group in the precious metals complex as any gains in the price flow straight to the bottom…

StockNews.com

Which Gold Miner is a Better Buy: Centerra Gold or Equinox Gold

Amid rising stock market volatility on concerns over inflation and Russia-Ukraine tensions are expected to drive the demand for gold because of its safe-haven nature. So, Centerra Gold Inc. (CGAU) and Equinox Gold Corp. (EQX) should benefit. But which of these two stocks is a better buy now? Read more…

Organisations

Barrick Gold Corporation

24 stories

Marqeta

24 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.